Stock Screen: Buy 'Em Like Buffett (at BusinessWeek)

Sanofi Aventis: New Real Life Studies Illustrate Greater A1C Lowering and Cost Benefit Observed With LANTUS(R) Over Detemir and NPH Insulin (PR Newswire)
Sanofi-aventis, a world leader in diabetes care, announced the results of three non-interventional studies presented at the 44th annual meeting of the European Association for the Study of Diabetes in Rome, Italy , which demonstrated that treatment with LANTUS® (insulin glargine injection):

High-Risk Acquisition The Right Prescription For Pfizer? (at Investopedia)

Outsourcing the Drug Industry (BusinessWeek)
U.S. giants are rushing to partner with Indian and Chinese companies -- tapping their brainpower and saving millions of dollars in the search for breakthrough treatments